Cadent Therapeutics
Industry
- Biotechnology
- Pharmaceuticals
Other Names/Subsidiaries
- Ataxion
- Luc Therapeutics Inc.
- Mnemosyne Pharmaceuticals
Latest on Cadent Therapeutics
Novartis AG has hit the acquisition trail again to buy up the pipeline of Cadent Therapeutics , having already collaborated for five years with the US biotech on an depression drug. Privately held C
Biomatics Capital Partners closed its second fund focused on breakthrough science and technology in health care, bringing in $300m to fund the development of therapeutics, diagnostics, research and de
IN VITRO DIAGNOSTICS Financings Biocept Inc. Biocept Inc. (blood-based molecular diagnostics for solid tumors) netted $8.7mm through the sale of 4.3mm common shares at $2.15 (a slight discount) to
Biopharmaceutical start-ups brought in 19% less funding in the first quarter of 2017 as compared with the previous quarter, but venture capital investors placed big bets on a few new companies, includ